
    
      OUTLINE: This is a multi-center study.

      Sample Collection:

        -  Core biopsy

        -  Blood sample

           28-day Cycle Treatment Regimen:

        -  Paclitaxel 90 mg/m2 IV D1, 8, and 15

        -  Avastin 10 mg/kg IV D1 and 15

      ECOG Performance Status of 0 or 1

      Life Expectancy: Not specified

      Hematopoietic:

        -  Platelet count > 100,000/mm³

        -  Absolute neutrophil count > 1200/mm³

        -  PTT < 1.5 x upper limit of normal

        -  INR < 1.5 x upper limit of normal

      Hepatic:

        -  Total bilirubin < 1.5 mg/dL

        -  SGOT (AST) < 2 x upper limit of normal

      Renal: Not specified

      Cardiovascular:

        -  Clinically significant cardiovascular or cerebrovascular disease including prior
           myocardial infarction (within 6 months prior to study entry), unstable angina, Grade II
           or greater peripheral vascular disease, New York Heart Association (NYHA) Grade II or
           greater congestive heart failure, hypertensive crises, hypertensive encephalopathy or
           uncontrolled hypertension (SBP>150, DBP>100).
    
  